AR080874A1 - Emulsiones aceite en agua termicamente estables conteniendo un aceite que contiene acidos grasos poli-insaturados. proceso. - Google Patents
Emulsiones aceite en agua termicamente estables conteniendo un aceite que contiene acidos grasos poli-insaturados. proceso.Info
- Publication number
- AR080874A1 AR080874A1 ARP110101194A ARP110101194A AR080874A1 AR 080874 A1 AR080874 A1 AR 080874A1 AR P110101194 A ARP110101194 A AR P110101194A AR P110101194 A ARP110101194 A AR P110101194A AR 080874 A1 AR080874 A1 AR 080874A1
- Authority
- AR
- Argentina
- Prior art keywords
- acid
- water
- emulsion
- emulsion according
- oil containing
- Prior art date
Links
- 239000000839 emulsion Substances 0.000 title abstract 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 title 1
- 229930195729 fatty acid Natural products 0.000 title 1
- 239000000194 fatty acid Substances 0.000 title 1
- 150000004665 fatty acids Chemical class 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 abstract 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- 235000021294 Docosapentaenoic acid Nutrition 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract 2
- 239000003963 antioxidant agent Substances 0.000 abstract 2
- 230000003078 antioxidant effect Effects 0.000 abstract 2
- 235000006708 antioxidants Nutrition 0.000 abstract 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 abstract 2
- QRYRORQUOLYVBU-VBKZILBWSA-N carnosic acid Chemical compound CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 abstract 2
- 239000003995 emulsifying agent Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 150000002772 monosaccharides Chemical class 0.000 abstract 2
- 239000007764 o/w emulsion Substances 0.000 abstract 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 abstract 2
- 239000003381 stabilizer Substances 0.000 abstract 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 abstract 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 abstract 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical class O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 abstract 1
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 abstract 1
- 229920001817 Agar Polymers 0.000 abstract 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- 229920000084 Gum arabic Polymers 0.000 abstract 1
- 229920000881 Modified starch Polymers 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- 235000010489 acacia gum Nutrition 0.000 abstract 1
- 239000000205 acacia gum Substances 0.000 abstract 1
- 239000008272 agar Substances 0.000 abstract 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 abstract 1
- 239000000420 anogeissus latifolia wall. gum Substances 0.000 abstract 1
- 235000021342 arachidonic acid Nutrition 0.000 abstract 1
- 229940114079 arachidonic acid Drugs 0.000 abstract 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 abstract 1
- 235000010418 carrageenan Nutrition 0.000 abstract 1
- 239000000679 carrageenan Substances 0.000 abstract 1
- 229920001525 carrageenan Polymers 0.000 abstract 1
- 229940113118 carrageenan Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229940108924 conjugated linoleic acid Drugs 0.000 abstract 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 1
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 abstract 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 abstract 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 229960002733 gamolenic acid Drugs 0.000 abstract 1
- 235000019314 gum ghatti Nutrition 0.000 abstract 1
- 235000010445 lecithin Nutrition 0.000 abstract 1
- 239000000787 lecithin Substances 0.000 abstract 1
- 229940067606 lecithin Drugs 0.000 abstract 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 abstract 1
- 229960004488 linolenic acid Drugs 0.000 abstract 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 abstract 1
- 235000019136 lipoic acid Nutrition 0.000 abstract 1
- 230000000873 masking effect Effects 0.000 abstract 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000001814 pectin Substances 0.000 abstract 1
- 235000010987 pectin Nutrition 0.000 abstract 1
- 229920001277 pectin Polymers 0.000 abstract 1
- 150000002989 phenols Chemical class 0.000 abstract 1
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract 1
- 235000013824 polyphenols Nutrition 0.000 abstract 1
- 229920000136 polysorbate Polymers 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 229960003080 taurine Drugs 0.000 abstract 1
- 229960002663 thioctic acid Drugs 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
- 239000000230 xanthan gum Substances 0.000 abstract 1
- 235000010493 xanthan gum Nutrition 0.000 abstract 1
- 229920001285 xanthan gum Polymers 0.000 abstract 1
- 229940082509 xanthan gum Drugs 0.000 abstract 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Birds (AREA)
- Colloid Chemistry (AREA)
- Edible Oils And Fats (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Seasonings (AREA)
Abstract
Reivindicacion 1: Una emulsion aceite en agua térmicamente estable que comprende: un aceite comprendiendo un ácido graso poliinsaturado, agua, un emulsionante, y un estabilizante soluble en agua seleccionado de: una mezcla de cloruro de sodio y un monosacárido, una mezcla de propilenglicol y un monosacárido, y glicerol, caracterizado porque el estabilizante soluble en agua está presente en una concentracion de 20% hasta 50% en peso de la emulsion, y caracterizada porque la emulsion aceite en agua térmicamente estable es fluida a una temperatura de -40°C, y está libre de una variacion en el tamano de las partículas después de 9 meses en almacenamiento a una temperatura de -40°C hasta -15°C. Reivindicacion 7: La emulsion de acuerdo con cualquiera de las Reivindicaciones 1 a 6, caracterizada porque el ácido graso poli-insaturado se selecciona de: ácido alfa-linolénico, ácido gamma-linolénico, ácido linoleico, ácido linoleico conjugado, ácido araquidonico, ácido docosapentaenoico omega-3, ácido docosapentaenoico omega-6, ácido eicosapentaenoico, ácido docosahexaenoico, oxilipinas, así como combinaciones de los mismos. Reivindicacion 10: La emulsion de acuerdo con cualquiera de las Reivindicaciones 1 a 9, caracterizada porque el emulsionante se selecciona de: una goma acacia modificada, una lecitina, un agar, una goma ghatti modificada, una pectina, una carragenina, una goma xantano, un almidon alimenticio modificado, un alginato modificado, un éster de sorbitán polioxietilenado, un éster de azucar, así como combinaciones de los mismos. Reivindicacion 21: La emulsion de acuerdo con cualquiera de las Reivindicaciones 1 a 20, que comprende además un agente para el enmascaramiento del gusto. Reivindicacion 23: La emulsion de acuerdo con cualquiera de las Reivindicaciones 1 a 22, que comprende además un antioxidante. Reivindicacion 24: La emulsion de acuerdo con la Reivindicacion 23, caracterizada porque el antioxidante se selecciona de: vitamina C, vitamina E, un polifenol, un derivado de fenol, ácido carnosico, ácido lipoico, taurina, un ácido carboxílico aromático, así como combinaciones de los mismos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32274710P | 2010-04-09 | 2010-04-09 | |
| US35041010P | 2010-06-01 | 2010-06-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR080874A1 true AR080874A1 (es) | 2012-05-16 |
Family
ID=44763265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110101194A AR080874A1 (es) | 2010-04-09 | 2011-04-08 | Emulsiones aceite en agua termicamente estables conteniendo un aceite que contiene acidos grasos poli-insaturados. proceso. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9585837B2 (es) |
| EP (1) | EP2555761B1 (es) |
| JP (1) | JP5936234B2 (es) |
| KR (1) | KR101809770B1 (es) |
| CN (1) | CN102939079B (es) |
| AR (1) | AR080874A1 (es) |
| BR (1) | BR112012025813A2 (es) |
| CA (1) | CA2795195C (es) |
| EA (1) | EA026128B1 (es) |
| MX (1) | MX2012011671A (es) |
| TW (1) | TWI530559B (es) |
| WO (1) | WO2011127163A1 (es) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011162802A1 (en) | 2010-06-21 | 2011-12-29 | Virun, Inc. | Compositions containing non-polar compounds |
| US20140154377A1 (en) * | 2011-04-04 | 2014-06-05 | Dsm Ip Assets B.V. | Oil-in-water emulsions comprising a polyunsaturated fatty acid and methods of making the same |
| US20120251685A1 (en) * | 2011-04-04 | 2012-10-04 | Martek Biosciences Corporation | Oil-in-Water Emulsions Comprising a Polyunsaturated Fatty Acid and Methods of Making the Same |
| KR102008038B1 (ko) * | 2011-11-29 | 2019-08-06 | 아트-피 | 인체의 유전체 특성을 시뮬레이션한 조성물 및 sar 측정을 위한 이의 사용 |
| AU2013208915B2 (en) * | 2012-01-11 | 2016-03-17 | Dsm Ip Assets B.V. | Organic emulsion comprising DHA and EPA |
| US10874122B2 (en) | 2012-02-10 | 2020-12-29 | Virun, Inc. | Beverage compositions containing non-polar compounds |
| JP6222642B2 (ja) * | 2012-04-06 | 2017-11-01 | 学校法人神奈川大学 | 乳化剤、エマルション、乳化剤の製造方法、及び乳化剤製造用原料 |
| WO2014121141A1 (en) * | 2013-01-31 | 2014-08-07 | Oberto Sausage Company | Protein-based food product incorporating a heat-stable emulsion |
| US20150374018A1 (en) * | 2013-02-04 | 2015-12-31 | Firmenich Sa | Shelf stable spray dried particles |
| US9351517B2 (en) | 2013-03-15 | 2016-05-31 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and compositions containing same |
| JP6400089B2 (ja) * | 2013-06-21 | 2018-10-03 | フイルメニツヒ ソシエテ アノニムFirmenich Sa | メントールを含有する乾燥粒子の製造 |
| US9693574B2 (en) | 2013-08-08 | 2017-07-04 | Virun, Inc. | Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch |
| US9683130B2 (en) | 2014-03-19 | 2017-06-20 | Xerox Corporation | Polydiphenylsiloxane coating formulation and method for forming a coating |
| US9494884B2 (en) | 2014-03-28 | 2016-11-15 | Xerox Corporation | Imaging plate coating composite composed of fluoroelastomer and aminosilane crosslinkers |
| US9428663B2 (en) | 2014-05-28 | 2016-08-30 | Xerox Corporation | Indirect printing apparatus employing sacrificial coating on intermediate transfer member |
| JP6299689B2 (ja) * | 2014-07-24 | 2018-03-28 | 三生医薬株式会社 | 生体吸収促進剤含有組成物 |
| US9611404B2 (en) * | 2014-09-23 | 2017-04-04 | Xerox Corporation | Method of making sacrificial coating for an intermediate transfer member of indirect printing apparatus |
| US9550908B2 (en) | 2014-09-23 | 2017-01-24 | Xerox Corporation | Sacrificial coating for intermediate transfer member of an indirect printing apparatus |
| US9593255B2 (en) | 2014-09-23 | 2017-03-14 | Xerox Corporation | Sacrificial coating for intermediate transfer member of an indirect printing apparatus |
| US9421758B2 (en) | 2014-09-30 | 2016-08-23 | Xerox Corporation | Compositions and use of compositions in printing processes |
| US9956760B2 (en) | 2014-12-19 | 2018-05-01 | Xerox Corporation | Multilayer imaging blanket coating |
| US9458341B2 (en) | 2015-02-12 | 2016-10-04 | Xerox Corporation | Sacrificial coating compositions comprising polyvinyl alcohol and waxy starch |
| US9816000B2 (en) | 2015-03-23 | 2017-11-14 | Xerox Corporation | Sacrificial coating and indirect printing apparatus employing sacrificial coating on intermediate transfer member |
| US10537123B2 (en) * | 2015-04-30 | 2020-01-21 | Kraft Foods Group Brands Llc | Quillaja-stabilized liquid beverage concentrates and methods of making same |
| EP3297452A4 (en) * | 2015-05-19 | 2019-01-16 | Ralco Nutrition, Inc. | COMPOSITIONS OF ESSENTIAL OILS AND APPLICATIONS USING ESSENTIAL OILS |
| DE102015010608A1 (de) * | 2015-08-18 | 2017-02-23 | Brauns-Heitmann Gmbh & Co. Kg | Basiskomponente und Glanzkomponente für ein wässriges Eierfärbemittel |
| US9718964B2 (en) | 2015-08-19 | 2017-08-01 | Xerox Corporation | Sacrificial coating and indirect printing apparatus employing sacrificial coating on intermediate transfer member |
| ES2607715B1 (es) * | 2015-10-01 | 2018-01-17 | Solutex Na, Lcc | Proceso para la preparación y estabilización de emulsiones con omega-3 mediante redes cristalinas isométricas de derivados de celulosa |
| WO2018062554A1 (ja) | 2016-09-30 | 2018-04-05 | 三栄源エフ・エフ・アイ株式会社 | 低分子ガティガム |
| KR102581019B1 (ko) | 2017-03-31 | 2023-09-22 | 산에이겐 에후.에후. 아이. 가부시키가이샤 | 유화 조성물 |
| US20210093578A1 (en) * | 2017-04-27 | 2021-04-01 | Clover Corporation Limited | Encapsulated nutritional and pharmaceutical compositions |
| US20210024883A1 (en) * | 2017-09-14 | 2021-01-28 | Agency For Science, Technology And Research | Emulsions, methods and uses thereof |
| WO2019132983A1 (en) * | 2017-12-29 | 2019-07-04 | Spectrum Brands, Inc. | Novel palatable pet food composition |
| GB2613276A (en) * | 2017-12-29 | 2023-05-31 | Spectrum Brands Inc | Novel palatable pet food composition |
| JP7138838B2 (ja) * | 2018-04-23 | 2022-09-20 | 池田食研株式会社 | 機能性成分含有飲食品 |
| CN109380700A (zh) * | 2018-11-08 | 2019-02-26 | 天津科技大学 | 一种大蒜精油微胶囊及其制备方法 |
| CN109852474A (zh) * | 2019-04-16 | 2019-06-07 | 海南舒普生物科技有限公司 | 一种鼠尾草酸水溶产品及其制备方法 |
| IT201900006573A1 (it) * | 2019-05-06 | 2020-11-06 | Gricar Chemical S R L | Composizione liquida per la veicolazione di sostanze a bassa solubilità e bio-accessibilità enterica |
| CN110507611A (zh) * | 2019-08-23 | 2019-11-29 | 中国医科大学 | 一种鼠尾草酸纳米乳口服液及其制备方法 |
| US20210059278A1 (en) * | 2019-09-04 | 2021-03-04 | Pepsico, Inc. | Process for preparing transparent emulsions |
| WO2021076718A1 (en) * | 2019-10-15 | 2021-04-22 | Capsugel Belgium Nv | Oil-in-water emulsions and methods of use |
| US11478991B2 (en) | 2020-06-17 | 2022-10-25 | Xerox Corporation | System and method for determining a temperature of an object |
| US11499873B2 (en) | 2020-06-17 | 2022-11-15 | Xerox Corporation | System and method for determining a temperature differential between portions of an object printed by a 3D printer |
| US11498354B2 (en) | 2020-08-26 | 2022-11-15 | Xerox Corporation | Multi-layer imaging blanket |
| US11460416B2 (en) | 2020-09-30 | 2022-10-04 | Saudi Arabian Oil Company | Method for measuring oil in water using multi-frequency microwave measurements |
| WO2022132902A1 (en) * | 2020-12-16 | 2022-06-23 | Pano Therapeutics, Inc. | Capsaicin and trpv1 modulator compositions and methods of use thereof |
| US11767447B2 (en) | 2021-01-19 | 2023-09-26 | Xerox Corporation | Topcoat composition of imaging blanket with improved properties |
| CN118177289A (zh) * | 2023-11-29 | 2024-06-14 | 广东海大集团股份有限公司 | 一种复合多维纳米乳剂的制备方法与应用 |
| CN118872835B (zh) * | 2024-07-16 | 2025-03-11 | 青岛农业大学 | 一种高冻融稳定性淀粉基蛋黄酱及其制备方法和应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3572354A (en) * | 1969-11-21 | 1971-03-23 | Halliburton Co | Method of reducing friction losses in the flow of aqueous fluids |
| US4146652A (en) * | 1977-01-28 | 1979-03-27 | Rich Products Corporation | Intermediate moisture, ready-to-use frozen whippable foods |
| US4199604A (en) * | 1977-01-28 | 1980-04-22 | Rich Products Corporation | Intermediate-moisture, ready-to-use, frozen non dairy creamer |
| US5156652A (en) | 1986-12-05 | 1992-10-20 | Canadian Occidental Petroleum Ltd. | Low-temperature pipeline emulsion transportation enhancement |
| PT743824E (pt) * | 1994-02-14 | 2002-10-31 | Rich Products Corp | Alimentos com melhor desempenho de batimento e maior estabilidade termica |
| US6426078B1 (en) * | 1997-03-17 | 2002-07-30 | Roche Vitamins Inc. | Oil in water microemulsion |
| IL138616A0 (en) * | 2000-09-21 | 2001-10-31 | J P M E D Ltd | Oil in glycerin emulsion |
| AU4402600A (en) * | 1999-05-18 | 2000-12-05 | Rawlings, Anthony V. | Fat containing products |
| US6596336B1 (en) * | 1999-05-21 | 2003-07-22 | Lipton, Division Of Conopco, Inc. | Microbiologically stable sauce emulsion |
| US20020188024A1 (en) * | 2000-08-23 | 2002-12-12 | Chilton Floyd H. | Fatty acid-containing emulsion with increased bioavailability |
| EP1597973A1 (en) * | 2004-05-18 | 2005-11-23 | Nestec S.A. | Oil-in-water emulsion for delivery |
| CN101553136A (zh) * | 2006-09-06 | 2009-10-07 | 可口可乐公司 | 稳定的多不饱和脂肪酸乳液及用于防止、抑制或降低多不饱和脂肪酸在乳液中降解的方法 |
| US20080058418A1 (en) * | 2006-09-06 | 2008-03-06 | The Coca-Cola Company | Stable polyunsaturated fatty acid emulsions and methods for inhibiting, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion |
| WO2008039564A1 (en) * | 2006-09-25 | 2008-04-03 | Bob Comstock | Process for solubilization of flavor oils |
| PL2134197T5 (pl) * | 2007-04-16 | 2016-07-29 | Unilever Bcs Europe Bv | Jadalne emulsje ze składnikiem mineralnym |
| WO2009006317A1 (en) | 2007-06-29 | 2009-01-08 | Martek Biosciences Corporation | Production and purification of esters of polyunsaturated fatty acids |
| BRPI0909187A2 (pt) * | 2008-03-20 | 2015-08-04 | Virun Inc | Emulsões incluindo tocoferol de derivados de peg |
| EP2309879B1 (en) * | 2008-07-15 | 2016-03-30 | Comstock, Robert Lawrence | Improved emulsifying system for nutraceutical composition |
| WO2010040012A1 (en) | 2008-10-01 | 2010-04-08 | Martek Biosciences Corporation | Compositions and methods for reducing triglyceride levels |
| WO2010091853A2 (en) * | 2009-02-11 | 2010-08-19 | Dsm Ip Assets B.V. | High concentrated pufa emulsions |
| US9717703B2 (en) * | 2009-10-16 | 2017-08-01 | Glaxosmithkline Llc | Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed |
-
2011
- 2011-04-06 MX MX2012011671A patent/MX2012011671A/es active IP Right Grant
- 2011-04-06 JP JP2013503890A patent/JP5936234B2/ja active Active
- 2011-04-06 CN CN201180028627.2A patent/CN102939079B/zh active Active
- 2011-04-06 KR KR1020127029301A patent/KR101809770B1/ko active Active
- 2011-04-06 US US13/640,106 patent/US9585837B2/en active Active
- 2011-04-06 EP EP11766653.7A patent/EP2555761B1/en active Active
- 2011-04-06 CA CA2795195A patent/CA2795195C/en active Active
- 2011-04-06 BR BR112012025813A patent/BR112012025813A2/pt not_active Application Discontinuation
- 2011-04-06 US US13/080,894 patent/US20120083530A1/en not_active Abandoned
- 2011-04-06 EA EA201201380A patent/EA026128B1/ru not_active IP Right Cessation
- 2011-04-06 WO PCT/US2011/031410 patent/WO2011127163A1/en not_active Ceased
- 2011-04-08 AR ARP110101194A patent/AR080874A1/es active IP Right Grant
- 2011-04-08 TW TW100112208A patent/TWI530559B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| TWI530559B (zh) | 2016-04-21 |
| CA2795195A1 (en) | 2011-10-13 |
| EA201201380A1 (ru) | 2013-04-30 |
| EP2555761A1 (en) | 2013-02-13 |
| TW201139652A (en) | 2011-11-16 |
| US20120083530A1 (en) | 2012-04-05 |
| CA2795195C (en) | 2018-05-08 |
| EP2555761B1 (en) | 2023-11-15 |
| CN102939079B (zh) | 2016-01-06 |
| US9585837B2 (en) | 2017-03-07 |
| KR20130097068A (ko) | 2013-09-02 |
| CN102939079A (zh) | 2013-02-20 |
| JP5936234B2 (ja) | 2016-06-22 |
| BR112012025813A2 (pt) | 2016-06-28 |
| JP2013527795A (ja) | 2013-07-04 |
| MX2012011671A (es) | 2012-12-17 |
| US20130210916A1 (en) | 2013-08-15 |
| KR101809770B1 (ko) | 2017-12-15 |
| EA026128B1 (ru) | 2017-03-31 |
| MX348075B (es) | 2017-05-25 |
| EP2555761A4 (en) | 2013-09-11 |
| WO2011127163A1 (en) | 2011-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR080874A1 (es) | Emulsiones aceite en agua termicamente estables conteniendo un aceite que contiene acidos grasos poli-insaturados. proceso. | |
| CL2019003105A1 (es) | Lípidos extraídos de plantas que comprenden ácidos grasos poliinsaturados de cadena larga. (divisional solicitud 201601560) | |
| RU2014138996A (ru) | Гормонсодержащая эмульсия | |
| PH12016500100B1 (en) | Self-emulsifying composition of omega3 fatty acid | |
| JP2014516249A5 (es) | ||
| CY1117616T1 (el) | Διαδικασια για την απομονωση φωσφολιπιδιου | |
| MX342216B (es) | Composiciones de acidos grasos. | |
| PE20140578A1 (es) | Emulsion que se puede montar a temperatura ambiente | |
| PE20140459A1 (es) | Composicion de fluido acarreador que comprende etil esteres de acidos grasos y proceso para la reduccion de la concentracion de contaminantes organicos persistentes en aceite de pescado | |
| MX383445B (es) | Composiciones alimenticias para mascotas. | |
| JP2014532773A5 (es) | ||
| MX2012004546A (es) | Sustitutos de crema liquida con antioxidantes. | |
| NZ757794A (en) | Encapsulated nutritional and pharmaceutical compositions | |
| WO2016040570A3 (en) | Dietary emulsion formulations and methods for using the same | |
| CO2019002445A2 (es) | Composición para aplicación tópica con actividad antifúngica | |
| AR076184A1 (es) | Formulaciones farmaceuticas que comprenden 9-cis-retinil esteres en un vehiculo lipidico. metodo. | |
| BR112015028696A2 (pt) | composições de óleo estruturadas | |
| PE20211003A1 (es) | Composiciones de acidos grasos poliinsaturados enriquecidos con dha | |
| ES2782832T3 (es) | Composición antioxidante destinada a la estabilización oxidativa de aceites marinos, animales o vegetales | |
| CA2798577A1 (en) | Synergistic antioxidant composition | |
| PE20211482A1 (es) | Composiciones de acidos grasos poliinsaturados enriquecidos con dha | |
| EA201692398A1 (ru) | Гомогенная композиция для перорального введения, содержащая омега-3 полиненасыщенные жирные кислоты и ресвератрол | |
| CL2023002953A1 (es) | Composiciones de ácidos grasos poliinsaturados enriquecidos | |
| CL2018001200A1 (es) | Emulsión de gas en aceite en agua y método para su preparación. | |
| CL2022000255A1 (es) | Composición lipídica que comprende antioxidantes y polifenoles naturales como alternativa no farmacológica para el tratamiento y la prevención de nafld. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal | ||
| FG | Grant, registration |